Delivery Order SPE2DB25D3404-SPE2DB25FUMYU

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Nurtec ODT 75 mg tablets and has a ceiling value of $15,359.33. The contract type is Firm Fixed Price and the performance period extends to May 1, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nurtec ODT 75 mg tablets. The contract has a ceiling value of $28,492.11 and a period of performance through May 5, 2025. It is a firm-fixed-price contract, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,930.27, is for the delivery of Nurtec ODT 75 mg tablets over a period ending on May 6, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider, for the supply of Nurtec ODT 75 mg tablets. The contract has a ceiling value of $4,838.91 and an ultimate completion date of September 7, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,142,121 units of the pharmaceutical product Nurtec ODT 75 mg tablets. The contract has a ceiling value of $22,127.02 and a completion date of May 6, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Nurtec ODT 75 mg tablets, with a ceiling value of $46,131.01 and a completion date of March 12, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $41,015.15, is for the delivery of Nurtec ODT 75 mg tablets. It is a firm fixed-price, non-set-aside contract with a period of performance through April 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $56,112.76, is for the supply of the prescription medication Nurtec ODT 75 mg tablets. It is a firm fixed-price contract with a period of performance through May 2, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NURTEC ODT 75 MG TABLET 8S. The contract has a total ceiling value of $2,575.93 and an ultimate completion date of November 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nurtec ODT 75 mg tablets. The contract has a firm fixed price of $4,071.41 and a completion date of October 11, 2024. This contract is not set aside for any special designation. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which serves as a...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUMYU
    Delivery Order

This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nurtec ODT 75 mg tablets. The contract has a ceiling value of $26,723.65 and a period of performance through April 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order is likely part of the company's broader efforts to supply pharmaceuticals and medical supplies to support military healthcare programs and other government agencies.

Generated 7/17/25, 6:20 PM